KBC Securities advice for Pharming
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| March 06, 2014 | KBC Securities | Pharming | Buy | 0.70 EUR |
Advice details
Brussel - Op 06 Mar 2014 herhalen de analisten van KBC Securities hun koopadvies voor the Dutch pharmaceutical company Pharming (ISIN: NL0010391025 / Mnemo: PHARM). Het 12-maands koersdoel wordt opwaarts bijgesteld van 0.2 EUR naar 0.7 EUR.
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2025 ValueSpectrum. All Rights Reserved
Developed and maintained by 